Monash BDI Welcomes 18 New Group Leaders in 2025
The Monash Biomedicine Discovery Institute (BDI) is delighted to announce the appointment of 18 new Group Leaders in 2025. This milestone reflects the Institute’s ongoing commitment to nurturing the next generation of research leaders and supporting early career researchers (ECRs) as they transition from senior postdoctoral roles to independent lab heads.
The Group Leader program provides formal recognition and career momentum for researchers who are leading innovative, high-impact research and establishing their own scientific identities.
Professor Dena Lyras, Deputy Director of Monash BDI, congratulated the cohort.
“I extend my warmest congratulations to our newly appointed Group Leaders,” Professor Lyras said.
“Their selection is a testament to their scientific excellence, leadership potential and dedication to advancing biomedical research. We are excited to support their journey and look forward to the discoveries they will make.”
These appointments highlight Monash BDI’s vibrant research culture and its role as one of Australia’s largest biomedical research institutes, home to more than 120 research teams working to address global health challenges.
New Monash BDI Group Leaders in 2025: Dr Nafiseh Atapour, Dr Ram Bhusal, Dr Wei Cao, Dr Denny Cottle, Dr Evan Healy, Dr Melanie Hutton, Dr Bob Leung, Dr Meagan McGrath, Dr Steven Mileto, Dr Joanne O'Donnell, Dr Daisuke Shimaoka, Dr Matthew Snelson, Dr Joel Steele, Dr Christopher Stubenrauch, Dr Cyntia Taveneau, Dr Praveena Thirunavukkarasu, Dr Luis Valentin-Alvarado and Dr Hsiao Voon.
Congratulations to the 2025 Monash BDI Group Leaders
Dr Nafiseh Atapour, Department of Physiology, Neuroscience Program
Dr Ram Bhusal, Department of Biochemistry and Molecular Biology, Immunity Program
Dr Wei Cao, Department of Anatomy and Developmental Biology; Development and Stem Cells Program
Dr Denny Cottle, Department of Anatomy and Developmental Biology; Development and Stem Cells Program
Dr Evan Healy, Department of Biochemistry and Molecular Biology, Cancer Program
Dr Melanie Hutton, Department of Microbiology, Infection Program
Dr Bob Leung, Department of Microbiology, Infection Program
Dr Meagan McGrath, Department of Biochemistry and Molecular Biology, Metabolism, Diabetes and Obesity Program
Dr Steven Mileto, Department of Microbiology, Infection Program
Dr Joanne O'Donnell, Department of Pharmacology, Cardiovascular Disease Program
Dr Daisuke Shimaoka, Department of Physiology, Neuroscience Program
Dr Matthew Snelson, Department of Pharmacology, Cardiovascular Disease Program
Dr Joel Steele, Department of Biochemistry and Molecular Biology
Dr Christopher Stubenrauch, Department of Microbiology, Infection Program
Dr Cyntia Taveneau,Department of Biochemistry and Molecular Biology, InfectionProgram
Dr Praveena Thirunavukkarasu, Department of Biochemistry and Molecular Biology, Immunity Program
Dr Luis Valentin-Alvarado, Department of Biochemistry and Molecular Biology, InfectionProgram
Dr Hsiao Voon, Department of Biochemistry and Molecular Biology; Cancer Program
-
GENERAL MEDIA ENQUIRIES
For more Monash media stories, visit our news and events site
Monash Media
E: media@monash.edu
T: +61 (0) 3 9903 4840
About the Monash Biomedicine Discovery Institute at Monash University
Committed to making discoveries that will relieve the future burden of disease, Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally renowned research teams. Spanning seven discovery programs across Cancer, Cardiovascular Disease, Development and Stem Cells, Infection, Immunity, Metabolism, Diabetes and Obesity, and Neuroscience, Monash BDI is one of the largest biomedical research institutes in Australia. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.